StockData
Gilead Sciences, Inc. logo

Gilead Sciences, Inc. (GILD) operating KPIs

GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.68+5.07 (+3.06%)

Close on Oct 30, 2026Market cap $211.64BP/E –Yield 1.85%

Gilead Sciences trodelvy (sacituzumab govitecan-hziy — TROP-2 ADC) ($M) ($M)

Form 10-Q / 10-K Disaggregated Revenue Note & Form 8-K Product Sales Summary

QuarterlyAnnual
Latest, Q2 2026
457
Period ended Jun 30, 2026
Change on a year earlier
+25.5%
364 in Q2 2025
History
26 quarters
Since Q1 2020
Sources
21
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTrodelvy (sacituzumab govitecan-hziy — TROP-2 ADC) ($M) ($M)Year on yearSource
Q2 2026Jun 30, 2026457+25.5%Form 10-Q (filed 2026-08-06) ↗
Q1 2026Mar 31, 2026402+37.2%Form 10-Q (filed 2026-05-07) ↗
Q4 2025Dec 31, 2025384+8.2%Form 10-K (filed 2026-02-24) ↗
Q3 2025Sep 30, 2025357+7.5%Form 10-Q (filed 2025-11-07) ↗
Q2 2025Jun 30, 2025364+13.7%Form 10-Q (filed 2026-08-06) ↗
Q1 2025Mar 31, 2025293-5.2%Form 10-Q (filed 2026-05-07) ↗
Q4 2024Dec 31, 2024355+18.7%Form 10-K (filed 2026-02-24) ↗
Q3 2024Sep 30, 2024332+17.3%Form 10-Q (filed 2025-11-07) ↗
Q2 2024Jun 30, 2024320+23.1%Form 10-Q (filed 2025-08-07) ↗
Q1 2024Mar 31, 2024309+39.2%Form 10-Q (filed 2025-05-07) ↗
Q4 2023Dec 31, 2023299+53.3%Form 10-K (filed 2026-02-24) ↗
Q3 2023Sep 30, 2023283+57.2%Form 10-Q (filed 2024-11-12) ↗
Q2 2023Jun 30, 2023260+63.5%Form 10-Q (filed 2024-08-08) ↗
Q1 2023Mar 31, 2023222+52.1%Form 10-Q (filed 2024-05-08) ↗
Q4 2022Dec 31, 2022195+65.3%Form 10-K (filed 2025-02-28) ↗
Q3 2022Sep 30, 2022180+78.2%Form 10-Q (filed 2023-11-07) ↗

Breakdown

What makes up trodelvy (sacituzumab govitecan-hziy — trop-2 adc) ($m)

Cite this data

StockData. (2026). Gilead Sciences Trodelvy (sacituzumab govitecan-hziy — TROP-2 ADC) ($M) ($M), quarterly Q1 2020–Q2 2026 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/onc_trodelvy

See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.